- ADJUNCT ASSOCIATE PROFESSOR Medicine, Gastroenterology
- Sharmila Anandasabapathy, MD, completed her internal medicine training at the New York Hospital/Cornell Medical Center, New York, and her gastroenterology fellowship at The Mount Sinai Medical Center. After spending several years in Houston at the M.D. Anderson Cancer Center, she returned to Mount Sinai's Division of Gastroenterology as Chief of Endoscopy in October 2008. Dr. Anandasabapathy's clinical interests are in gastroesophageal reflux disease, Barrett's esophagus, and gastrointestinal cancers. She is also interested in endoscopic imaging, including endoscopic ultrasound and confocal microendoscopy. Her research interests focus on the early diagnosis and treatment of Barrett's esophagus and esophageal cancer, including endoscopic mucosal resection and ablative technologies. She has several active research protocols looking at the early detection of gastrointestinal cancers. Dr. Anandasabapathy graduated from Yale University and is a former literature major. When she is not scoping, she enjoys reading, travelling, and running in Central Park with her family and Shih-Tzu, Max.
Dr. Anandasabapathy is the Medical Director of Endoscopy. Visit the Endoscopy Suite to learn more about our state-of-the-art care.
In the News
Dr. Anandasabapathy discusses esophageal cancer in The Daily News feature "The Daily Check Up." View the PDF.
Advanced ImagingDr. Anandasabapathy currently holds a joint appointment in Biomedical Engineering at Rice University with whom she collaborates on three ongoing clinical trials evaluating novel methods of imaging early cancer in the gastrointestinal tract.
Barrett's esophagus and esophageal cancer: early detection and minimally-invasive treatmentWe have 6 ongoing clinical trials (both NIH, Industry and foundation supported) in Barrett's esophagus including a longitudinal study with the National Cancer Institute, and several other studies evaluating diagnostic and treatment strategies in Barrett's and esophageal cancer.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Anandasabapathy did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Annenberg Building Floor 7 Room 48
1468 Madison Avenue
New York, NY 10029